RGRX - RegeneRx Biopharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue93.30860.612-
Cost of Revenue---
Gross Profit93.30860.612-
Operating Expenses
Research Development237.344203.185367.275
Selling General and Administrative1,529.9831,566.9621,188.211
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-1,674.019-1,709.535-1,555.486
Income from Continuing Operations
Total Other Income/Expenses Net2,076.499-3,388.065-1,014.683
Earnings Before Interest and Taxes402.48-5,097.6-2,570.169
Interest Expense173.355172.883183.473
Income Before Tax229.125-5,270.483-2,753.642
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops229.125-5,270.483-2,753.642
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income229.125-5,270.483-2,753.642
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares229.125-5,270.483-2,753.642